This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by NISHIDA, S. Articles by OYAMA, H. Search for Related Content PubMed PubMed Citation Articles by NISHIDA, S. Articles by OYAMA, H.

Effects of Changes in Angiotensin Converting Enzyme Activity on Renin Release: Pretreatment with Dexamethasone Enhances a Plasma Renin Activity Response to Captopril in Normal Subjects^*

Division of Endocrinology, Department of Medicine, Kawasaki Medical School Kurashiki, Okayama, Japan

Address requests for reprints to: Seikoh Nishida, Division of Endocrinology, Department of Medicine, Kawasaki Medical School, Kurashiki, Okayama, 701–01 Japan.

Healthy adults were given captopril (25 mg and 75 mg) po with or without dexamethasone (DXM) pretreatment (1 mg po 2 h before and simultaneously with the captopril). We determined the serum potassium and sodium concentrations, plasma prostaglandin E₂ level, PRA, serum angiotensin converting enzyme (ACE) activity, and aldosterone level from 20 min before to 120 min after administration of captopril. DXM pretreatment stimulated the PRA response to captopril. This stimulation was suppressed by indomethacin. However, the administration of DXM did not induce a consistent rise in the prostaglandin E₂ level. The administration of DXM induced a significant rise in the potassium concentration, but since simultaneous administration of indomethacin with captopril induced the suppression of PRA without affecting the potassium level, the PRA increase in response to captopril with DXM was not caused directly by the potassium increase. There were no significant differences in the PRA increase between 25 mg captopril and 75 mg captopril, or between DXM-25 mg captopril and DXM-75 mg captopril, though the inhibitions of ACE activity by captopril differed according to dose. The PRA increases, but not the captopril-induced inhibition of ACE activity, were significantly different between captopril alone and captopril with DXM pretreatment at either dose of captopril. Thus, the inhibition of ACE activity perhaps allows PRA to increase in response to captopril. These results suggest that the DXM stimulation of PRA may have been dependent on the inhibition of ACE activity by captopril.

^* This work was supported in part by Research Project Grants 61–606, 62–304, and 63–401 (to S.N.) from the Kawasaki Medical School.

Received January 2, 1990.

This article has been cited by other articles:

				Y. Ogura, S. Matsuda, M. Ito, R. Niimi, M. Sumitomo, and Y. Kawarada Chemoprevention of biliary carcinogenesis in Syrian hamsters by the novel carboxamide derivative IS-741 after initiation with N-nitrosobis(2-oxopropyl)amine (BOP) Carcinogenesis, August 1, 2000; 21(8): 1469 - 1475. [Abstract] [Full Text] [PDF]